
Mark A. Robinson
Examiner (ID: 7620)
| Most Active Art Unit | 2872 |
| Art Unit(s) | 2872, 2883, 2507 |
| Total Applications | 772 |
| Issued Applications | 600 |
| Pending Applications | 39 |
| Abandoned Applications | 133 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8660181
[patent_doc_number] => 20130041010
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-14
[patent_title] => 'COMPOSITIONS AND METHODS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DSRNA CONTAINING MODIFIED NUCLEOTIDES'
[patent_app_type] => utility
[patent_app_number] => 13/346331
[patent_app_country] => US
[patent_app_date] => 2012-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 29195
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13346331
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/346331 | COMPOSITIONS AND METHODS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DSRNA CONTAINING MODIFIED NUCLEOTIDES | Jan 8, 2012 | Abandoned |
Array
(
[id] => 8606129
[patent_doc_number] => 20130011441
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-10
[patent_title] => 'TARGETED DELIVERY OF siRNA'
[patent_app_type] => utility
[patent_app_number] => 13/345494
[patent_app_country] => US
[patent_app_date] => 2012-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 20692
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13345494
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/345494 | TARGETED DELIVERY OF siRNA | Jan 5, 2012 | Abandoned |
Array
(
[id] => 8265311
[patent_doc_number] => 20120164730
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-28
[patent_title] => 'COMPOSITIONS FOR SILENCING THE EXPRESSION OF VDAC1 AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/337986
[patent_app_country] => US
[patent_app_date] => 2011-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 17483
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13337986
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/337986 | COMPOSITIONS FOR SILENCING THE EXPRESSION OF VDAC1 AND USES THEREOF | Dec 26, 2011 | Abandoned |
Array
(
[id] => 8323883
[patent_doc_number] => 20120196293
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-02
[patent_title] => 'METHOD AND KIT FOR IN VITRO DIAGNOSIS OF ATHEROSCLEROSIS'
[patent_app_type] => utility
[patent_app_number] => 13/334798
[patent_app_country] => US
[patent_app_date] => 2011-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4641
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13334798
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/334798 | METHOD AND KIT FOR IN VITRO DIAGNOSIS OF ATHEROSCLEROSIS | Dec 21, 2011 | Abandoned |
Array
(
[id] => 10586621
[patent_doc_number] => 09308217
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-04-12
[patent_title] => 'Targeting glioma stem cells by sequence-specific functional inhibition of pro-survival oncomir-138'
[patent_app_type] => utility
[patent_app_number] => 13/996114
[patent_app_country] => US
[patent_app_date] => 2011-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 8
[patent_no_of_words] => 13969
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13996114
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/996114 | Targeting glioma stem cells by sequence-specific functional inhibition of pro-survival oncomir-138 | Dec 19, 2011 | Issued |
Array
(
[id] => 8127495
[patent_doc_number] => 20120088298
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-12
[patent_title] => 'IKKALPHA AND IKKBETA SPECIFIC INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 13/329607
[patent_app_country] => US
[patent_app_date] => 2011-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 7975
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0088/20120088298.pdf
[firstpage_image] =>[orig_patent_app_number] => 13329607
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/329607 | IKKALPHA AND IKKBETA SPECIFIC INHIBITORS | Dec 18, 2011 | Abandoned |
Array
(
[id] => 8419247
[patent_doc_number] => 20120246747
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-27
[patent_title] => 'RNA-INTERFERENCE BY SINGLE-STRANDED RNA MOLECULES'
[patent_app_type] => utility
[patent_app_number] => 13/329710
[patent_app_country] => US
[patent_app_date] => 2011-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 12320
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13329710
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/329710 | RNA-INTERFERENCE BY SINGLE-STRANDED RNA MOLECULES | Dec 18, 2011 | Abandoned |
Array
(
[id] => 8265965
[patent_doc_number] => 20120165396
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-28
[patent_title] => 'MODULATION OF EXPORTIN 5 EXPRESSION'
[patent_app_type] => utility
[patent_app_number] => 13/330262
[patent_app_country] => US
[patent_app_date] => 2011-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26098
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13330262
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/330262 | Modulation of exportin 5 expression | Dec 18, 2011 | Issued |
Array
(
[id] => 8503532
[patent_doc_number] => 20120302940
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-29
[patent_title] => 'Popcorn Shape Gold Nanoparticle For Targeted Diagnosis, Photothermal Treatment and In-Situ Monitoring Therapy Response for Cancer and Multiple Drug Resistance Bacteria'
[patent_app_type] => utility
[patent_app_number] => 13/307652
[patent_app_country] => US
[patent_app_date] => 2011-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 12586
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13307652
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/307652 | Popcorn Shape Gold Nanoparticle For Targeted Diagnosis, Photothermal Treatment and In-Situ Monitoring Therapy Response for Cancer and Multiple Drug Resistance Bacteria | Nov 29, 2011 | Abandoned |
Array
(
[id] => 8043617
[patent_doc_number] => 20120071541
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-22
[patent_title] => 'Micro-RNA Associated With Rheumatoid Arthritis'
[patent_app_type] => utility
[patent_app_number] => 13/304768
[patent_app_country] => US
[patent_app_date] => 2011-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 6101
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0071/20120071541.pdf
[firstpage_image] =>[orig_patent_app_number] => 13304768
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/304768 | Micro-RNA associated with rheumatoid arthritis | Nov 27, 2011 | Issued |
Array
(
[id] => 8465751
[patent_doc_number] => 20120270920
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-25
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATMENT OF POUCHITIS'
[patent_app_type] => utility
[patent_app_number] => 13/299291
[patent_app_country] => US
[patent_app_date] => 2011-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31689
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13299291
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/299291 | Compositions and methods for treatment of pouchitis | Nov 16, 2011 | Issued |
Array
(
[id] => 7808094
[patent_doc_number] => 20120059048
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-08
[patent_title] => 'METHODS FOR DIAGNOSING AND TREATING SQUAMOUS CELL CARCINOMA UTILIZING miRNA-205 AND INHIBITORS THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/295427
[patent_app_country] => US
[patent_app_date] => 2011-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 10420
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20120059048.pdf
[firstpage_image] =>[orig_patent_app_number] => 13295427
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/295427 | METHODS FOR DIAGNOSING AND TREATING SQUAMOUS CELL CARCINOMA UTILIZING miRNA-205 AND INHIBITORS THEREOF | Nov 13, 2011 | Abandoned |
Array
(
[id] => 8347345
[patent_doc_number] => 20120208267
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-16
[patent_title] => 'System for Synergistic Expression of Multiple Small Functional RNA Elements'
[patent_app_type] => utility
[patent_app_number] => 13/296121
[patent_app_country] => US
[patent_app_date] => 2011-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11122
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13296121
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/296121 | System for Synergistic Expression of Multiple Small Functional RNA Elements | Nov 13, 2011 | Abandoned |
Array
(
[id] => 9468779
[patent_doc_number] => 08722409
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-05-13
[patent_title] => 'Cofilin knockdown host cells and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 13/294759
[patent_app_country] => US
[patent_app_date] => 2011-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6707
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13294759
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/294759 | Cofilin knockdown host cells and uses thereof | Nov 10, 2011 | Issued |
Array
(
[id] => 8227350
[patent_doc_number] => 20120141549
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-07
[patent_title] => 'OLIGONUCLEOTIDES TARGETING ASTHMA INFLAMMATION PROCESSES'
[patent_app_type] => utility
[patent_app_number] => 13/280777
[patent_app_country] => US
[patent_app_date] => 2011-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 12959
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13280777
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/280777 | OLIGONUCLEOTIDES TARGETING ASTHMA INFLAMMATION PROCESSES | Oct 24, 2011 | Abandoned |
Array
(
[id] => 8523438
[patent_doc_number] => 20120322846
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-12-20
[patent_title] => 'METHODS AND COMPOSITIONS FOR ENHANCING THE EFFICACY AND SPECIFICITY OF SINGLE AND DOUBLE BLUNT-ENDED siRNA'
[patent_app_type] => utility
[patent_app_number] => 13/270920
[patent_app_country] => US
[patent_app_date] => 2011-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 10883
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13270920
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/270920 | METHODS AND COMPOSITIONS FOR ENHANCING THE EFFICACY AND SPECIFICITY OF SINGLE AND DOUBLE BLUNT-ENDED siRNA | Oct 10, 2011 | Abandoned |
Array
(
[id] => 8221830
[patent_doc_number] => 20120136040
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-31
[patent_title] => 'HYBRID INTERFERING RNA'
[patent_app_type] => utility
[patent_app_number] => 13/271052
[patent_app_country] => US
[patent_app_date] => 2011-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9963
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13271052
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/271052 | HYBRID INTERFERING RNA | Oct 10, 2011 | Abandoned |
Array
(
[id] => 9042464
[patent_doc_number] => 20130245102
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-19
[patent_title] => 'NOVEL DNA TEMPLATES FOR SMALL RNA PRODUCTION IN MAMMALIAN CELLS'
[patent_app_type] => utility
[patent_app_number] => 13/879254
[patent_app_country] => US
[patent_app_date] => 2011-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 20967
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13879254
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/879254 | NOVEL DNA TEMPLATES FOR SMALL RNA PRODUCTION IN MAMMALIAN CELLS | Oct 10, 2011 | Abandoned |
Array
(
[id] => 9710832
[patent_doc_number] => 08835400
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-09-16
[patent_title] => 'RNA molecules that upregulate insulin production'
[patent_app_type] => utility
[patent_app_number] => 13/877991
[patent_app_country] => US
[patent_app_date] => 2011-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 15
[patent_no_of_words] => 18678
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13877991
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/877991 | RNA molecules that upregulate insulin production | Oct 9, 2011 | Issued |
Array
(
[id] => 8381408
[patent_doc_number] => 20120225034
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-06
[patent_title] => 'AGENTS USEFUL IN TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY'
[patent_app_type] => utility
[patent_app_number] => 13/225384
[patent_app_country] => US
[patent_app_date] => 2011-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 30188
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13225384
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/225384 | AGENTS USEFUL IN TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY | Sep 1, 2011 | Abandoned |